Director, Inflation Reduction Act Strategy & Planning

AbbVie•Mettawa, IL

About The Position

The Director, Inflation Reduction Act Strategy & Planning is a business-critical role at AbbVie, created in response to the significant impact of the Inflation Reduction Act (IRA) on the pharmaceutical industry. This director will act as a subject matter expert, providing strategic direction and cross-functional leadership to help AbbVie proactively manage IRA-related risks and opportunities for both current commercial brands and future pipeline products.

Requirements

Bachelor's degree in business or related discipline.
12+ years of progressive experience in highly regulated commercial business; pharmaceutical or healthcare industry strongly preferred.
Strong leadership skills with proven ability to drive cross-functional teams and lead complex projects.
Exceptional communication, negotiation, and interpersonal abilities.
Demonstrated analytical thinking and problem-solving skills.

Nice To Haves

Master's degree highly desirable to ensure ability to consult on business strategy development and analyze information to build insights.
Advanced degree in life sciences, business, public policy, or related field preferred.
Extensive experience in the pharmaceutical industry, ideally in portfolio risk management, market access, or strategic planning roles.
Deep understanding of the US healthcare policy and regulatory landscape; specific knowledge of the IRA is highly valued.

Responsibilities

Partner closely with Commercial Therapeutics, US Market Access, Global Commercial Development (GCD), Finance, Government Affairs, and Legal to understand and dissect IRA’s potential effects on individual brands and pipeline assets.
Be the subject matter expert for therapeutic area leaders, Integrated Brand Teams (IBTs), and Asset Strategy Teams (ASTs) on the implications and timelines of IRA implementation and its long-term impact, raising organizational acumen and preparedness.
Develop and lead a structured framework for the ongoing evaluation and risk assessment of on-market and pipeline assets, collaborating with IBTs and ASTs.
Identify and prioritize risks posed by the IRA over the Long Range Plan (LRP) for each asset and facilitate cross-functional risk-navigating teams to propose and drive effective mitigation strategies, including life cycle management, negotiation alternatives, and evidence generation.
Contribute to portfolio-wide risk stratification and segmentation, enabling AbbVie to focus resources and innovation on areas of greatest need and potential impact.
Support organizational innovation by driving solutions that minimize IRA risk and maximize opportunity for patients, AbbVie, and the broader industry.